Global Payer Evidence and Pricing, Global Product Portfolio Strategy, Astrazeneca, Pepparedsleden 1, Mölndal 43183, Sweden
Currently working in Global Payer Evidence and Pricing.
Clinical; Respiratory; Asthma; Chronic obstructive pulmonary disease
Journal of Lung Diseases & Treatment received 247 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 